Literature DB >> 11388131

Treatment of hypertension in a managed care setting.

L DiTusa1, A B Luzier, D E Jarosz, B D Snyder, J L Izzo.   

Abstract

BACKGROUND: Based on recommendations of the Fifth and Sixth Reports of the Joint National Committee (JNC) on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, Health Care Plan (now Univera Healthcare) Buffalo, NY, developed a clinical guideline to improve the management of patients with hypertension. To increase awareness and utilization, the guideline was distributed as hard copy reports and made available through our electronic information system.
OBJECTIVE: To determine blood pressure (BP) control rates and adherence to guideline recommendations. STUDY
DESIGN: Retrospective chart review. PATIENTS AND METHODS: We randomly sampled hypertensive patients seen during 1998 to evaluate hypertension management. Computerized medical and pharmacy records were reviewed for patient demographics, antihypertensive medications, comorbid conditions, and BP readings. Patient assessment was based on antihypertensive regimen and achievement of target BP according to the recommendations of the guidelines (< 140/90 mm Hg for the general population and < 130/85 mm Hg for special populations). In addition, we assessed control rates using traditional Health Plan Employer Data and Information Set (HEDIS) measures (< 140/90 mm Hg).
RESULTS: Overall, 35% of patients achieved target BP and 68% were treated with agents recommended by our JNC-based guideline. In contrast, using traditional HEDIS measures, 41% of patients achieved BP control. Of 39 patients with compelling indications (primarily diabetic patients), 13% achieved BP target and 67% were treated with recommended agents.
CONCLUSIONS: The impact of our clinical guideline is reflected through the relatively high utilization of recommended drugs. However, optimal BP control continues to be problematic. In particular, patients with diabetes warrant focused attention.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11388131

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  5 in total

1.  Achieving good glycemic control: initiation of new antihyperglycemic therapies in patients with type 2 diabetes from the Kaiser Permanente Northern California Diabetes Registry.

Authors:  Andrew J Karter; Howard H Moffet; Jennifer Liu; Melissa M Parker; Ameena T Ahmed; Assiamira Ferrara; Joe V Selby
Journal:  Am J Manag Care       Date:  2005-04       Impact factor: 2.229

Review 2.  Treatment and blood pressure control in 47,964 people with diabetes and hypertension: a systematic review of observational studies.

Authors:  Donna L McLean; Scot H Simpson; Finlay A McAlister; Ross T Tsuyuki
Journal:  Can J Cardiol       Date:  2006-08       Impact factor: 5.223

3.  Hypertension guideline adherence among nursing home patients.

Authors:  Paul E Drawz; Cristina Bocirnea; Katarina B Greer; Julian Kim; Florian Rader; Patrick Murray
Journal:  J Gen Intern Med       Date:  2009-02-07       Impact factor: 5.128

Review 4.  Systems for care of hypertension in the United States.

Authors:  Lawrence R Krakoff
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-06       Impact factor: 3.738

5.  Associations of metabolic disorder factors with the risk of uncontrolled hypertension: a follow-up cohort in rural China.

Authors:  Jing Xiao; Tianqi Hua; Huan Shen; Min Zhang; Xiao-Jian Wang; Yue-Xia Gao; Qinyun Lu; Chuanli Wu
Journal:  Sci Rep       Date:  2017-04-07       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.